tiprankstipranks
Advertisement
Advertisement

CGON Stock Latest News

CG Oncology price target raised to $90 from $60 at UBS
The FlyCG Oncology price target raised to $90 from $60 at UBS
11h ago
CGON
Cretostimogene’s PIVOT‑6 Upside: Anticipated Superiority in Recurrence‑Free Survival Supports Buy on CG Oncology
PremiumRatings
Cretostimogene’s PIVOT‑6 Upside: Anticipated Superiority in Recurrence‑Free Survival Supports Buy on CG Oncology
2d ago
CGON
CG Oncology price target raised to $72 from $65 at BofA
PremiumThe Fly
CG Oncology price target raised to $72 from $65 at BofA
13d ago
JNJ
CGON
Buy Rating on CG Oncology Driven by PIVOT-006 Differentiation and 2026 Clinical, Regulatory Catalysts Supporting Favorable Risk–Reward
PremiumRatings
Buy Rating on CG Oncology Driven by PIVOT-006 Differentiation and 2026 Clinical, Regulatory Catalysts Supporting Favorable Risk–Reward
24d ago
CGON
CG Oncology: Advancing Creto Toward 2026 BLA with Pivotal PIVOT‑006 Catalyst and Expanding NMIBC Peak Sales Potential
PremiumRatings
CG Oncology: Advancing Creto Toward 2026 BLA with Pivotal PIVOT‑006 Catalyst and Expanding NMIBC Peak Sales Potential
27d ago
CGON
CG Oncology price target raised to $80 from $75 at H.C. Wainwright
PremiumThe FlyCG Oncology price target raised to $80 from $75 at H.C. Wainwright
27d ago
CGON
CG Oncology reports FY25 EPS ($2.08), consensus (58c)
Premium
The Fly
CG Oncology reports FY25 EPS ($2.08), consensus (58c)
27d ago
CGON
CG Oncology sees cash runway into 1H29
Premium
The Fly
CG Oncology sees cash runway into 1H29
27d ago
CGON
CG Oncology price target raised to $75 from $66 at Truist
PremiumThe Fly
CG Oncology price target raised to $75 from $66 at Truist
1M ago
CGON
CG Oncology price target raised to $73 from $61 at RBC Capital
PremiumThe Fly
CG Oncology price target raised to $73 from $61 at RBC Capital
2M ago
CGON
CG Oncology price target raised to $70 from $55 at Piper Sandler
PremiumThe Fly
CG Oncology price target raised to $70 from $55 at Piper Sandler
2M ago
CGON
Oncolytics appoints John McAdory as EVP, strategy and operations
PremiumThe Fly
Oncolytics appoints John McAdory as EVP, strategy and operations
2M ago
CGON
ONCY
CG Oncology Expands At-The-Market Equity Offering Capacity
PremiumCompany AnnouncementsCG Oncology Expands At-The-Market Equity Offering Capacity
2M ago
8K
CGON
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AIM
CGON
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
AIM
CGON
CG Oncology price target raised to $66 from $62 at Truist
PremiumThe Fly
CG Oncology price target raised to $66 from $62 at Truist
2M ago
CGON
CG Oncology price target raised to $82 from $55 at Goldman Sachs
PremiumThe Fly
CG Oncology price target raised to $82 from $55 at Goldman Sachs
2M ago
CGON
Top 5 Trending Stocks by Unusual Trading Volume, 1/10/26
PremiumMarket News
Top 5 Trending Stocks by Unusual Trading Volume, 1/10/26
3M ago
CGON
EPLC
Accelerated PIVOT-006 Timeline and Expanded NMIBC Opportunity Drive CG Oncology Target Hike to $108 and Reinforce Buy Rating
PremiumRatings
Accelerated PIVOT-006 Timeline and Expanded NMIBC Opportunity Drive CG Oncology Target Hike to $108 and Reinforce Buy Rating
3M ago
CGON
Accelerated Creto Trajectory in NMIBC Drives Earlier Data, De-Risked Commercialization, and Higher $66 Target Supporting Buy Rating on CG Oncology
PremiumRatingsAccelerated Creto Trajectory in NMIBC Drives Earlier Data, De-Risked Commercialization, and Higher $66 Target Supporting Buy Rating on CG Oncology
3M ago
CGON
CG Oncology price target raised to $66 from $62 at Truist
Premium
The Fly
CG Oncology price target raised to $66 from $62 at Truist
3M ago
CGON
CG Oncology price target raised to $93 from $89 at Morgan Stanley
Premium
The Fly
CG Oncology price target raised to $93 from $89 at Morgan Stanley
3M ago
CGON

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >